http://www.*.com.au/companies/news/42709/nusep-r...

http://www.proactiveinvestors.com.au/companies/news/42709/nusep-raises-cash-from-placement-to-singapore-investor--42709.html

"Singapore-based PrIME Biologics is building a plasma fractionation facility in Singapore to address the US$1 billion Asian Therapeutic Plasma products market."

"Earlier this year PrIME Biologics successfully completed three trial production runs of Human Albumin, therapeutic grade human plasma, in Singapore."


"NuSep is moving closer to completing the $15 million funding for PrIME Biologics which will assume a valuation of $50 million for the subsidiary"

Clearly indicates $15m for 30% of PriME, after the transcation, NSP still hold 60%, 60%*50m=$30m

$30m/138m shares= 23c per share plus the upside potential after cashed up...........

Surely this investor is anticipating 100-300% return, so if the upside potential is $0.23-0.69 per share.

I think this cornerstone investment is most likely fom

BAXTER